A highly experimental new medical treatment to grow a liver inside someone's body has just hit a major milestone. After TK of development, the biotech company LyGenesis has announced that for the first time a human patient has been dosed with a

The all-treatments group is still taking roughly twice as long as the all-controls group (starting from 19 months old, when the experiment began) to get down to a given survival percentage in males. The all treatments female mice are lasting 50%